Early Access — free while we kick the tires
EdgarHawk

Murphy Matthew B.

General Counsel

Officer
1 filing analyzed · 1 company · Latest 2025-09-05

Companies

Company Buys Sells Direction
Nautilus Biotechnology, Inc. NAUT 1 0 Net buying

Activity

September 2025
high
Buy
20,000 shares
$12,858
Significance 5/10

General Counsel Murphy buys 20,000 shares at $0.64; holds 74,140 post-buy as stock down 78.6% from 52-week high

Matthew B. Murphy, General Counsel, purchased 20,000 shares of NAUT at $0.64, increasing his holdings by 36.9% to 74,140 shares. The timing is notable: the stock is trading at $0.66, down 78.6% from its 52-week high of $3.08, and the company posted net income of $-15,033,000.00 over its most recent full fiscal year. An insider purchase of this magnitude during significant price decline and continuing losses warrants investor attention to the motivations and timing, particularly given the 16.2% deterioration in the prior 30 days alone.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access